newsfilter
← Latest News
GlobeNewswire·

Exagen Inc. to Participate in the Canaccord Genuity 44th Annual Growth Conference

CARLSBAD, Calif., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (NASDAQ:XGN), a leading provider of autoimmune testing solutions, today announced its participation in the Canaccord Genuity 44th Annual Growth